Skip to main content
Caplight Logo









Scindo

Scindo

Private
LondonHealthcare & Life Scienceshttps://scindo.bio/

Last Round

Seed

Sep 23, 2025

Total Funding Raised

$5.65M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Scindo is a biotechnology company that has developed an AI-powered platform for enzyme discovery and engineering to transform renewable and recycled feedstocks into high-value bio-based ingredients.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

enzyme engineeringbiocatalysissynthetic biologybio-based ingredientsprotein designindustrial biotechnologysynbiosustainable chemistryai-driven discoveryspecialty chemicalsbiomanufacturingenzyme discoverygreen chemistrycell-free biocatalysiscircular economy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Scindo Comparables

Compare Scindo with similar companies based on industry and business-model similarity.

Scindo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
digzyme Inc.
83%
Biomatter
81%
Arzeda
77%

Scindo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 23, 2025
AcceleratorJun 11, 2020

Key People

Founding team and executive leadership

Juliet Sword

Co-Founder & COO

Founding Team

Gustaf Hemberg

Founder & CEO

Founding Team

Scindo Investors

Notable investors and investment history

Scindo investors
InvestorRounds
Farvatn VentureSeed
SynBioVenSeed
IndieBioAccelerator
Clay CapitalSeed
AgFunderSeed
Kadmos CapitalSeed
Savantus VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 148% MoM, reaching 2.1K.

  • Sep 23, 2025

    $5.4M raised in Seed round.

Scindo Filings

Explore SEC and related filing metadata, where available.

Scindo filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Scindo's valuation, stock price, and market status.

Is Scindo a public or private company?

Scindo is a private company.

What is the current stock price of Scindo?

Scindo is a private company with no public stock price. No recent secondary market data is available.

How much is Scindo worth (valuation)?

Valuation information for Scindo is not publicly available.

Can I buy Scindo stock?

Scindo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Scindo's last funding round?

Scindo's most recent funding round was Seed on September 23, 2025.

Who are the main investors in Scindo?

Key investors in Scindo include Clay Capital, Kadmos Capital, Clay Capital.

Will Scindo IPO soon?

No public IPO plans have been announced for Scindo.

How can I track Scindo secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Scindo's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range10
Year Founded2020
Last FundingSep 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?